Home » Topics » BioWorld Science

BioWorld Science
RSS

AbbVie presents BRD4 inhibitors

May 2, 2018

FDA grants priority review to sBLA for Keytruda

May 2, 2018

Actelion seeks FDA approval of Opsumit for inoperable chronic thromboembolic pulmonary hypertension

May 2, 2018

FDA approves Tafinlar + Mekinist for adjuvant treatment of BRAF V600-mutant melanoma

May 2, 2018

Hetero Labs divulges betulinic acid analogues for HIV infection

May 2, 2018

Lactobacillus reuteri may reduce bone loss in older women

May 2, 2018

Genocea files IND for phase I/IIa study of GEN-009

May 2, 2018

DKFZ patents novel KLK6 inhibitors

May 2, 2018

FDA approves Kymriah for relapsed or refractory large B-cell lymphoma

May 2, 2018

Spark Therapeutics sells priority review voucher to Jazz Pharmaceuticals

May 2, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 1, 2026.
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...